KP Tissue Inc. (TSX:KPT)
Canada · Delayed Price · Currency is CAD | Market Cap | 122.90M +30.4% |
| Revenue (ttm) | n/a |
| Net Income | 10.36M +166.3% |
| EPS | 1.03 +165.5% |
| Shares Out | 10.03M |
| PE Ratio | 11.86 |
| Forward PE | 12.53 |
| Dividend | 0.84 (6.86%) |
| Ex-Dividend Date | Dec 31, 2026 |
| Volume | 10,629 |
| Open | 12.52 |
| Previous Close | 12.40 |
| Day's Range | 12.24 - 12.52 |
| 52-Week Range | 9.40 - 13.78 |
| Beta | 0.38 |
| Analysts | Hold |
| Price Target | 13.13 (+7.18%) |
| Est. Earnings | Nov 17, 2026 |
About KP Tissue
KP Tissue Inc., through its interest in Kruger Products Inc., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through the Consumer and Away-From-Home segments. It offers bathroom and facial tissues, paper towels, and napkins. The company markets its products under Cashmere, Purex, Scotties, SpongeTowels, Bonterra and White Cloud. brand names, as well as under private labels. It sells its products through the retail channels, such as grocery stores, mass mercha... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 4 analysts, the average rating for KPT stock is "Hold." The 12-month stock price target is $13.13, which is an increase of 7.18% from the latest price.
News
What KP Tissue (KPT) Said on Its Q3 Earnings Call
KP Tissue TSE: KPT reported higher third-quarter revenue and earnings at Kruger Products, but executives said a decision on a new tissue facility would be delayed as they assess trade uncertainty and ...
KP Tissue Earnings Call Transcript: Q3 2026
Q3 revenue rose 5.1% and adjusted EBITDA grew 9.1% YoY, with growth across Canada and the U.S. Higher input costs remain a headwind; Q4 adjusted EBITDA is expected below Q3 but above Q4 2025, while the TAD facility timeline is delayed.
KP Tissue Earnings release: Q3 2026
KP Tissue released its Q3 2026 earnings on November 11, 2026, summarizing the period's financial results.
KP Tissue Slides: Q3 2026
KP Tissue has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on November 11, 2026.
KP Tissue Report: Q3 2026
KP Tissue published a report on November 11, 2026 containing material business information for investors and shareholders.
KP Tissue MD&A: Q3 2026
KP Tissue filed a regulatory document on November 11, 2026 disclosing important business information.
KP Tissue Declares a Quarterly Dividend of $0.21 per Common Share
Mississauga, Ontario--(Newsfile Corp. - November 11, 2026) - KP Tissue Inc. (TSX: KPT) (KPT) announced today that the Board of Directors has declared a quarterly dividend of $0.21 per common share, pa...
KP Tissue Releases Third Quarter 2026 Financial Results
Maintaining profitable growth despite uncertain economic outlook Mississauga, Ontario--(Newsfile Corp. - November 11, 2026) - KP Tissue Inc. (TSX: KPT) (KPT) reports the Q3 2026 financial and operatio...
RETRANSMISSION: KP Tissue to Release Its Financial Results and Those of Kruger Products Inc. for the Third Quarter of 2026
Mississauga, Ontario--(Newsfile Corp. - November 10, 2026) - KP Tissue Inc. (TSX: KPT) (KPT), which holds an interest in Kruger Products Inc. (Kruger Products), will release the financial results for ...
KP Tissue to Release Its Financial Results and Those of Kruger Products Inc. for the Third Quarter of 2026
Mississauga, Ontario--(Newsfile Corp. - October 8, 2026) - KP Tissue Inc. (TSX: KPT) (KPT), which holds an interest in Kruger Products Inc. (Kruger Products), will release the financial results for KP...
KP Tissue Q2 Earnings Call Highlights
KP Tissue TSE: KPT reported higher second-quarter revenue and adjusted EBITDA, supported by stronger U.S. sales volumes, improved performance at its Memphis facility and lower pulp prices. Management ...
KP Tissue Earnings Call Transcript: Q2 2026
Q2 2026 saw strong adjusted EBITDA growth of 25% year-over-year to CAD 90.6 million, driven by robust U.S. sales and lower pulp prices, while Canadian revenue declined due to market softness and consumer trade-down. The outlook for Q3 is stable, with continued focus on margin delivery, brand investment, and monitoring of tariffs and input costs.
KP Tissue Slides: Q2 2026
KP Tissue has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 13, 2026.
KP Tissue Earnings release: Q2 2026
KP Tissue released its Q2 2026 earnings on August 13, 2026, summarizing the period's financial results.
KP Tissue MD&A: Q2 2026
KP Tissue filed a regulatory document on August 13, 2026 disclosing important business information.
KP Tissue Report: Q2 2026
KP Tissue published a report on August 13, 2026 containing material business information for investors and shareholders.
KP Tissue Releases Second Quarter 2026 Financial Results
Maintaining strong momentum despite economic uncertainty Mississauga, Ontario--(Newsfile Corp. - August 13, 2026) - KP Tissue Inc. (TSX: KPT) (KPT) reports the Q2 2026 financial and operational result...
KP Tissue to Release its Financial Results and Those of Kruger Products Inc. for The Second Quarter of 2026
Mississauga, Ontario--(Newsfile Corp. - July 13, 2026) - KP Tissue Inc. (TSX: KPT) (KPT), which holds an interest in Kruger Products Inc. (Kruger Products), will release the financial results for KPT ...
KP Tissue Inc. Reports on Shareholders' Voting Results for the Election of Directors
Mississauga, Ontario--(Newsfile Corp. - June 15, 2026) - KP Tissue Inc. (TSX: KPT) (KPT) held its Annual Meeting (the Meeting) of shareholders today. All candidates proposed as directors were duly ele...
Independent Proxy Advisory Firms ISS and Glass Lewis Recommend KP Tissue Inc. Shareholders Vote "FOR" on all Resolutions at the Upcoming 2026 Annual Meeting of Shareholders
Shareholders are reminded to vote well in advance of the proxy deadline on June 11, 2026 at 11:00 a.m. (Eastern Time) Shareholder Questions or Require Voting Assistance?
KP Tissue Announces Filing and Mailing of the Management Proxy Materials in Connection with Its 2026 Annual Meeting of Shareholders
Your vote is important regardless of how many shares you own. Vote today.
KP Tissue Q1 Earnings Call Highlights
KP Tissue TSE: KPT reported higher first-quarter profitability despite essentially flat revenue, as lower pulp prices and reduced warehousing costs helped offset foreign exchange pressure and other co...
KP Tissue price target raised to C$12 from C$11 at TD Securities
TD Securities analyst Sean Steuart raised the firm’s price target on KP Tissue (KPTSF) to C$12 from C$11 and keeps a Hold rating on the shares.
KP Tissue Earnings Call Transcript: Q1 2026
Q1 2026 saw adjusted EBITDA rise 14.6% to CAD 86.9 million on stable revenue, with margin gains from lower pulp and warehousing costs. U.S. capacity is expanding with a new Memphis line, and a western U.S. TAD plant is planned for late 2028. No new price increases are currently announced.
KP Tissue Slides: Q1 2026
KP Tissue has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 14, 2026.